A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Additional file 8: Figure S7. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells
[stub]
2017
Figshare
Viability of primary EOC183A cells treated with GAELs alone or pretreated with the pan-caspase inhibitor QVD. No significant difference in cell viability was observed in the presence of QVD, with the exception of the cisplatin positive control. * significantly different from vehicle control; + significantly different from cisplatin alone; pâ
doi:10.6084/m9.figshare.c.3778562_d8.v1
fatcat:tahshe3plrc6db3mjki7bmuvrq